Beta Bionics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Sean T. Saint, with a market cap of $427.4M.
Common questions about Beta Bionics, Inc. Common Stock
Beta Bionics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on April 21, 2026. Analysts estimate revenue of $27.3M.
We use cookies for analytics. See our Privacy and Cookie Policy.